PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

HYUGA PRIMARY CARE Co.,Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

HYUGA PRIMARY CARE Co.,Ltd. owes ¥0.68 for every ¥1 it owns. Net profit fell 30% in the year to Mar 2026, and grew 9% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Mar 2026.

P/E ratio

25.2

Investors pay ¥25.2 for every ¥1 of HYUGA PRIMARY CARE Co.,Ltd.'s yearly profit, higher than 76% of Healthcare companies in Japan.

P/B ratio

5.43

The share price is 5.43 times HYUGA PRIMARY CARE Co.,Ltd.'s book value per share, higher than 89% of Healthcare companies in Japan.

Market cap

¥15.0 B

The total market value of all of HYUGA PRIMARY CARE Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 53% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥2.8 B

What HYUGA PRIMARY CARE Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥387.82

Net worth divided by the number of shares. The share price of ¥2,105 is 5.4 times this, which is the P/B above.

Return on equity (ROE)

24.3%

HYUGA PRIMARY CARE Co.,Ltd. earned 24.3% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Japan.

Owes vs Owns

0.68×

HYUGA PRIMARY CARE Co.,Ltd. owes ¥0.68 for every ¥1 it owns (moderate), higher than 83% of Healthcare companies in Japan.

Dividend yield

0.95%

HYUGA PRIMARY CARE Co.,Ltd. pays 0.95% of its share price as dividends a year, lower than 95% of dividend-paying Healthcare companies in Japan.

Revenue growth

+20%

Revenue rose 20% in the year to Mar 2026, and grew 22% a year on average over 3 years.

Profit growth

-30%

Net profit fell 30% in the year to Mar 2026, and grew 9% a year on average over 3 years.

Profit margin

4.2%

HYUGA PRIMARY CARE Co.,Ltd. keeps ¥4 of every ¥100 of revenue as net profit.

Cash quality

0.98×

Cash from HYUGA PRIMARY CARE Co.,Ltd.'s business was 0.98× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.

Interest cover

15.3×

HYUGA PRIMARY CARE Co.,Ltd.'s operating profit covered its interest costs 15.3 times in the year to Mar 2026.

Cash vs debt

Net debt

HYUGA PRIMARY CARE Co.,Ltd. had ¥2.2 B more debt than cash (net debt) at Mar 2026.

Questions

What is HYUGA PRIMARY CARE Co.,Ltd.'s P/E ratio?

Investors pay ¥25.2 for every ¥1 of HYUGA PRIMARY CARE Co.,Ltd.'s yearly profit, higher than 76% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For HYUGA PRIMARY CARE Co.,Ltd.: ¥15.0 B ÷ ¥2.8 B (30 Jun 2026) = 5.4.

What is HYUGA PRIMARY CARE Co.,Ltd.'s return on equity?

HYUGA PRIMARY CARE Co.,Ltd. earned 24.3% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Japan.

How much does HYUGA PRIMARY CARE Co.,Ltd. owe compared with what it owns?

HYUGA PRIMARY CARE Co.,Ltd. owes ¥0.68 for every ¥1 it owns (moderate), higher than 83% of Healthcare companies in Japan.

Does HYUGA PRIMARY CARE Co.,Ltd. pay a dividend?

Yes. HYUGA PRIMARY CARE Co.,Ltd. pays 0.95% of its share price as dividends a year, lower than 95% of dividend-paying Healthcare companies in Japan.

Is HYUGA PRIMARY CARE Co.,Ltd.'s revenue growing?

Revenue rose 20% in the year to Mar 2026, and grew 22% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.